Literature DB >> 11722041

Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG.

C Scharf1, H Redecker, F Duru, R Candinas, H P Brunner-La Rocca, A Gerber, O Bertel, M I Turina, W Kiowski.   

Abstract

BACKGROUND: Sudden cardiac death (SCD) is a major cause of death despite successful revascularization in patients with coronary artery disease. The signal-averaged ECG (SAECG) is a sensitive predictor of SCD and could be used in the screening strategy to select patients for prophylactic cardioverter implantation.
METHODS: The SAECG was recorded in 561 patients (mean age: 60 +/- 8.8 years) within 10 days of coronary artery bypass grafting. Signal-averaged ECG was performed with a bandpass filtering of 40 to 250 Hz for more than 250 beats until a noise level of 0.6 microV was achieved. All patients were followed for 5.5 +/- 1.2 years after the procedure.
RESULTS: Preoperative angiographic ejection fraction was at least 60% in 393 patients (72%), 40% to 60% in 126 patients (23%), and 40% or less in 28 patients (5%). There were 34 deaths, 10 of which were SCD. Late potentials were found in a total of 150 patients (27%) and were equally frequent preoperatively and postoperatively and among patients with (30%) and without (27%) SCD. The only predictors for overall mortality were age and a reduced ejection fraction.
CONCLUSIONS: Signal-averaged ECG did not predict prognosis in low-risk patients undergoing coronary artery bypass grafting.

Entities:  

Mesh:

Year:  2001        PMID: 11722041     DOI: 10.1016/s0003-4975(01)03180-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function.

Authors:  Ashraf S Al-Dadah; Rochus K Voeller; Paymon Rahgozar; Jennifer S Lawton; Marc R Moon; Michael K Pasque; Ralph J Damiano; Nader Moazami
Journal:  J Cardiothorac Surg       Date:  2007-01-12       Impact factor: 1.637

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.